Literature DB >> 27649641

Pharmacologically Induced Sex Hormone Fluctuation Effects on Resting-State Functional Connectivity in a Risk Model for Depression: A Randomized Trial.

Patrick MacDonald Fisher1,2, Camilla Borgsted Larsen1,2, Vincent Beliveau1,2,3, Susanne Henningsson1,4, Anja Pinborg3,5, Klaus Kähler Holst6, Peter Steen Jensen1,2, Claus Svarer1,2, Hartwig Roman Siebner1,3,4,7, Gitte Moos Knudsen1,2,3, Vibe Gedsoe Frokjaer1,2.   

Abstract

Women are at relatively greater lifetime risk for depression than men. This elevated risk in women is partly due to heightened risk during time periods characterized by marked fluctuations in sex hormones, including postpartum and perimenopausal periods. How sex hormone fluctuations contribute to heightened risk is not fully understood but may involve intrinsic functional connectivity. We induced a biphasic ovarian sex hormone fluctuation using the gonadotropin-releasing hormone agonist (GnRHa) goserelin to determine, with a randomized placebo-controlled design, intervention effects on or GnRHa-provoked depressive symptoms associations with change in resting-state functional connectivity (rs-FC) in 58 healthy women for six seeds (amygdala, hippocampus, anterior cingulate cortex, dorsal raphe, median raphe, and posterior cingulate cortex). GnRHa intervention did not significantly affect rs-FC in any seeds. Considering the GnRHa group only, the emergence of depressive symptoms following intervention was positively associated with amygdala-right temporal cortex and negatively associated with hippocampus-cingulate rs-FC. A test for mediation suggested that rs-FC changes in these networks marginally mediated the association between decrease in estradiol and increase in depressive symptoms in the GnRHa group (p=0.07). Our findings provide novel evidence-linking changes in rs-FC networks, the emergence of depressive symptoms and sex hormone fluctuations. Notably, we observed evidence that changes in rs-FC may represent a key neurobiological intermediary between molecular changes induced by hormone fluctuations and the emergence of depressive symptoms. Taken together, our findings indicate that sex hormone fluctuations may contribute to heightened risk for developing depressive symptoms by affecting intrinsic functional connectivity of key limbic brain structures.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27649641      PMCID: PMC5399242          DOI: 10.1038/npp.2016.208

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  46 in total

Review 1.  Statistics notes: Analysing controlled trials with baseline and follow up measurements.

Authors:  A J Vickers; D G Altman
Journal:  BMJ       Date:  2001-11-10

2.  Cytoarchitecture of the human dorsal raphe nucleus.

Authors:  K G Baker; G M Halliday; I Törk
Journal:  J Comp Neurol       Date:  1990-11-08       Impact factor: 3.215

3.  A component based noise correction method (CompCor) for BOLD and perfusion based fMRI.

Authors:  Yashar Behzadi; Khaled Restom; Joy Liau; Thomas T Liu
Journal:  Neuroimage       Date:  2007-05-03       Impact factor: 6.556

4.  Activity and connectivity of brain mood regulating circuit in depression: a functional magnetic resonance study.

Authors:  Amit Anand; Yu Li; Yang Wang; Jingwei Wu; Sujuan Gao; Lubna Bukhari; Vincent P Mathews; Andrew Kalnin; Mark J Lowe
Journal:  Biol Psychiatry       Date:  2005-05-15       Impact factor: 13.382

5.  Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence.

Authors:  R C Kessler; K A McGonagle; M Swartz; D G Blazer; C B Nelson
Journal:  J Affect Disord       Date:  1993 Oct-Nov       Impact factor: 4.839

6.  Hippocampal structural changes across the menstrual cycle.

Authors:  Xenia Protopopescu; Tracy Butler; Hong Pan; James Root; Margaret Altemus; Margaret Polanecsky; Bruce McEwen; David Silbersweig; Emily Stern
Journal:  Hippocampus       Date:  2008       Impact factor: 3.899

7.  Impact of analysis methods on the reproducibility and reliability of resting-state networks.

Authors:  Alexandre R Franco; Maggie V Mannell; Vince D Calhoun; Andrew R Mayer
Journal:  Brain Connect       Date:  2013-08-03

Review 8.  Hormone replacement therapy for cognitive function in postmenopausal women.

Authors:  A Lethaby; E Hogervorst; M Richards; A Yesufu; K Yaffe
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23

Review 9.  Sleep disorders as core symptoms of depression.

Authors:  David Nutt; Sue Wilson; Louise Paterson
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

10.  Resting states are resting traits--an FMRI study of sex differences and menstrual cycle effects in resting state cognitive control networks.

Authors:  Helene Hjelmervik; Markus Hausmann; Berge Osnes; René Westerhausen; Karsten Specht
Journal:  PLoS One       Date:  2014-07-24       Impact factor: 3.240

View more
  14 in total

1.  Functional MRI for Assessment of the Default Mode Network in Acute Brain Injury.

Authors:  Daniel Kondziella; Patrick M Fisher; Vibeke Andrée Larsen; John Hauerberg; Martin Fabricius; Kirsten Møller; Gitte Moos Knudsen
Journal:  Neurocrit Care       Date:  2017-12       Impact factor: 3.210

2.  Hormonal Cycle and Contraceptive Effects on Amygdala and Salience Resting-State Networks in Women with Previous Affective Side Effects on the Pill.

Authors:  Jonas Engman; Inger Sundström Poromaa; Lena Moby; Johan Wikström; Mats Fredrikson; Malin Gingnell
Journal:  Neuropsychopharmacology       Date:  2017-06-25       Impact factor: 7.853

3.  Cognitive processing of emotional information during menstrual phases in women with and without postpartum depression: differential sensitivity to changes in gonadal steroids.

Authors:  Miki Bloch; Liat Helpman; Eva Gilboa-Schechtman; Inbar Fried-Zaig
Journal:  Arch Womens Ment Health       Date:  2022-05-09       Impact factor: 4.405

Review 4.  Neurobiological mechanisms underlying sex-related differences in stress-related disorders: Effects of neuroactive steroids on the hippocampus.

Authors:  Katharina M Hillerer; David A Slattery; Belinda Pletzer
Journal:  Front Neuroendocrinol       Date:  2019-09-30       Impact factor: 8.606

Review 5.  Sex differences and the neurobiology of affective disorders.

Authors:  David R Rubinow; Peter J Schmidt
Journal:  Neuropsychopharmacology       Date:  2018-07-09       Impact factor: 7.853

6.  Consciousness in Neurocritical Care Cohort Study Using fMRI and EEG (CONNECT-ME): Protocol for a Longitudinal Prospective Study and a Tertiary Clinical Care Service.

Authors:  Anine P Skibsted; Moshgan Amiri; Patrick M Fisher; Annette Sidaros; Melita Cacic Hribljan; Vibeke Andrée Larsen; Joan Lilja S Højgaard; Miki Nikolic; John Hauerberg; Martin E Fabricius; Gitte Moos Knudsen; Kirsten Møller; Daniel Kondziella
Journal:  Front Neurol       Date:  2018-11-27       Impact factor: 4.003

7.  Acupuncture for perimenopausal depression: A protocol for a systematic review and meta-analysis.

Authors:  Xiao Xiao; Jiayuan Zhang; Yuxia Jin; Yunxia Wang; Qi Zhang
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889

Review 8.  Effectiveness and Safety of Acupuncture for Perimenopausal Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Xiao Xiao; Jiayuan Zhang; Yuxia Jin; Yunxia Wang; Qi Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2020-01-19       Impact factor: 2.629

9.  Disrupted Spontaneous Neural Activity Related to Cognitive Impairment in Postpartum Women.

Authors:  Jin-Xia Zheng; Yu-Chen Chen; Huiyou Chen; Liang Jiang; Fan Bo; Yuan Feng; Wen-Wei Tang; Xindao Yin; Jian-Ping Gu
Journal:  Front Psychol       Date:  2018-05-03

10.  Negative Association Between Allopregnanolone and Cerebral Serotonin Transporter Binding in Healthy Women of Fertile Age.

Authors:  Inger Sundström Poromaa; Erika Comasco; Torbjörn Bäckström; Marie Bixo; Peter Jensen; Vibe G Frokjaer
Journal:  Front Psychol       Date:  2019-01-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.